Cargando…

M(1)A and m(7)G modification-related genes are potential biomarkers for survival prognosis and for deciphering the tumor immune microenvironment in esophageal squamous cell carcinoma

BACKGROUND: Esophageal squamous cell carcinoma (ESCC) is the most common esophageal malignancy, and RNA methylation has been reported to be involved in the tumorigenesis of ESCC. However, no study has explored methylation modifications in m(1)A and m(7)G as prognostic markers for survival prediction...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Ruixi, Cheng, Xingyuan, Chi, Dongmei, Liu, Shiliang, Li, Qiaoqiao, Chen, Baoqing, Xi, Mian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10267068/ https://www.ncbi.nlm.nih.gov/pubmed/37314494 http://dx.doi.org/10.1007/s12672-023-00710-6

Ejemplares similares

Recent Advances in Combination of Immunotherapy and Chemoradiotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma
por: Wang, Ruixi, et al.
Publicado: (2022)

Phase I study of cisplatin and nanoparticle albumin‐bound‐paclitaxel combined with concurrent radiotherapy in locally advanced esophageal squamous cell carcinoma
por: Jiang, Hui, et al.
Publicado: (2023)

Trafficking protein TMED3 promotes esophageal squamous cell carcinoma
por: Yang, Yuxian, et al.
Publicado: (2023)

Association Between Lymphopenia and Survival Outcomes in Esophageal Carcinoma Patients Receiving Combined Immunotherapy and Chemoradiotherapy
por: Cheng, Xingyuan, et al.
Publicado: (2023)

Oral maintenance therapy using apatinib combined with S-1/capecitabine for esophageal squamous cell carcinoma with residual disease after definitive chemoradiotherapy
por: Chi, Dongmei, et al.
Publicado: (2021)

Characteristics and Treatment of Brain Metastases from Esophageal Squamous Cell Carcinoma
por: Li, Qiaoqiao, et al.
Publicado: (2018)

A phase II clinical trial of toripalimab combined with neoadjuvant chemoradiotherapy in locally advanced esophageal squamous cell carcinoma (NEOCRTEC1901)
por: Chen, Rui, et al.
Publicado: (2023)

Definitive concurrent chemoradiotherapy with docetaxel plus cisplatin versus 5-fluorouracil plus cisplatin in patients with esophageal squamous cell carcinoma: long-term follow-up results of a phase II randomized controlled trial
por: Jiang, Hui, et al.
Publicado: (2023)

The Impact of m1A Methylation Modification Patterns on Tumor Immune Microenvironment and Prognosis in Oral Squamous Cell Carcinoma
por: Gao, Li, et al.
Publicado: (2021)

M7G-Related lncRNAs predict prognosis and regulate the immune microenvironment in lung squamous cell carcinoma
por: Pan, Junfan, et al.
Publicado: (2022)

Recent advances of m(6)A methylation modification in esophageal squamous cell carcinoma
por: Zhang, Xiaoqing, et al.
Publicado: (2021)

Prognosis After Surgical Resection of M1a/M1b Esophageal Squamous Cell Carcinoma
por: Shim, Young Mog, et al.
Publicado: (2005)

The Role of m(6)A Modification and m(6)A Regulators in Esophageal Cancer
por: Li, Yuekao, et al.
Publicado: (2022)

Induction chemotherapy followed by definitive chemoradiotherapy versus chemoradiotherapy alone in esophageal squamous cell carcinoma: a randomized phase II trial
por: Liu, Shiliang, et al.
Publicado: (2021)

Prediction of Pathologic Response to Neoadjuvant Chemoradiotherapy in Patients with Esophageal Squamous Cell Carcinoma Incorporating Hematological Biomarkers
por: Wu, Yingjia, et al.
Publicado: (2021)

Comprehensive analysis of m(7)G modification patterns based on potential m(7)G regulators and tumor microenvironment infiltration characterization in lung adenocarcinoma
por: Ma, Shouzheng, et al.
Publicado: (2022)

Identification of M5c regulator-medicated methylation modification patterns for prognosis and immune microenvironment in glioma
por: Xiao, Zhenyong, et al.
Publicado: (2023)

Deciphering the Role of Selenoprotein M
por: Nunes, Lance G. A., et al.
Publicado: (2023)

Characterization of m6A Methylation Modification Patterns in Colorectal Cancer Determines Prognosis and Tumor Microenvironment Infiltration
por: Yue, Qingfang, et al.
Publicado: (2022)

The significance of m6A RNA methylation modification in prognosis and tumor microenvironment immune infiltration of cervical cancer
por: Guo, Yilin, et al.
Publicado: (2022)

The methylation modification of m6A regulators contributes to the prognosis of head and neck squamous cell carcinoma
por: Chen, Ying, et al.
Publicado: (2021)

Esophageal squamous cell carcinoma and prognosis in Taiwan
por: Cheng, Ya‐Fu, et al.
Publicado: (2018)

m6A regulator-mediated methylation modification patterns and tumor microenvironment immune infiltration with prognostic analysis in esophageal cancer
por: Sheng, Gaohong, et al.
Publicado: (2023)

Analysis of m(7)G methylation modification patterns and pulmonary vascular immune microenvironment in pulmonary arterial hypertension
por: Wang, Desheng, et al.
Publicado: (2022)

m7G-related genes predict prognosis and affect the immune microenvironment and drug sensitivity in osteosarcoma
por: Lin, Zili, et al.
Publicado: (2023)

Association of Sialic Acid–Binding Immunoglobulin-Like Lectin 15 With Phenotypes in Esophageal Squamous Cell Carcinoma in the Setting of Neoadjuvant Chemoradiotherapy
por: Zhou, Sha, et al.
Publicado: (2023)

CD163 as a marker of M2 macrophage, contribute to predict aggressiveness and prognosis of Kazakh esophageal squamous cell carcinoma
por: Hu, Jian Ming, et al.
Publicado: (2017)

A novel pyroptosis scoring model was associated with the prognosis and immune microenvironment of esophageal squamous cell carcinoma
por: Zhang, Zhan-Fei
Publicado: (2023)

Mitochondrial energy metabolism correlates with an immunosuppressive tumor microenvironment and poor prognosis in esophageal squamous cell carcinoma
por: Zhang, Zewei, et al.
Publicado: (2023)

TLR3 Expression is a Potential Prognosis Biomarker and Shapes the Immune-Active Tumor Microenvironment in Esophageal Squamous Cell Carcinoma
por: Su, Ruibing, et al.
Publicado: (2022)

m5C RNA Methylation Regulators Predict Prognosis and Regulate the Immune Microenvironment in Lung Squamous Cell Carcinoma
por: Pan, Junfan, et al.
Publicado: (2021)

Unilateral Cervical Nodal Metastasis Is an Independent Prognostic Factor for Esophageal Squamous Cell Carcinoma Patients Undergoing Chemoradiotherapy: A Retrospective Study
por: Zhang, Peng, et al.
Publicado: (2014)

High expression of PDGFA predicts poor prognosis of esophageal squamous cell carcinoma
por: Han, Na, et al.
Publicado: (2021)

An m7G-related lncRNA signature predicts prognosis and reveals the immune microenvironment in bladder cancer
por: Li, Zhenchi, et al.
Publicado: (2023)

Low RCAN1.2 mRNA Expression Is Associated with Poor Prognosis of Patients with Esophageal Squamous Cell Carcinoma
por: Yang, Haijun, et al.
Publicado: (2023)

Intratumoral microbiome impacts immune infiltrates in tumor microenvironment and predicts prognosis in esophageal squamous cell carcinoma patients
por: Zhang, Shuyue, et al.
Publicado: (2023)

A bioinformatic analysis study of m(7)G regulator-mediated methylation modification patterns and tumor microenvironment infiltration in glioblastoma
por: Wu, Xinrui, et al.
Publicado: (2022)

Elevated TAB182 enhances the radioresistance of esophageal squamous cell carcinoma through G2‐M checkpoint modulation
por: Cao, Yuandong, et al.
Publicado: (2021)

Ferroptosis patterns and tumor microenvironment infiltration characterization in esophageal squamous cell cancer
por: Zhang, Lu-Lu, et al.
Publicado: (2022)

m(6)A Regulator-Mediated Methylation Modification Model Predicts Prognosis, Tumor Microenvironment Characterizations and Response to Immunotherapies of Clear Cell Renal Cell Carcinoma
por: Xu, Wenhao, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_16kfa4bpr87l42vprl42vb1hec